USPTO serial 79159157
NEARMEDIC
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Nov 17, 2015
- Examiner
- LE, KHANH M
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with NEARMEDIC?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
Limited Liability Company "NEARMEDIC PLUS"
RU
Other trademarks owned by Limited Liability Company "NEARMEDIC PLUS"
Limited Liability Company "NEARMEDIC PLUS"
RU
Other trademarks owned by Limited Liability Company "NEARMEDIC PLUS"
Limited Liability Company "NEARMEDIC PLUS"
RU
Other trademarks owned by Limited Liability Company "NEARMEDIC PLUS"
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Max Vern
Max Vern Amster, Rothstein & Ebenstein LLP90 Park AvenueNew York, NY 10016UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemicals used in industry; chemicals used in science; carbonic hydrates; raw materials, namely, animal or vegetable albumin for industrial use; raw material, namely, animal albumen for industrial use; chemicals for use in industry, namely, cellulose derivatives; chemical reagents, other than for medical or veterinary purposes; stem cells other than for medical or veterinary purposes; diagnostic preparations, other than for medical or veterinary purposes; chemical substances for analyses in laboratories, other than for medical or veterinary purposes | SECTION 71 - CANCELLED | — |
| 005 | Pharmaceutical preparations including cell-based preparations for medical purposes including stem cells for the treatment of endocrine, nutritional, metabolic, oncological, hepatological, ophthalmic, respiratory, gastrointestinal, hematological, dermatological, neurological and immune system related diseases and disorders; biocides; biological preparations for the prevention and treatment of infectious, endocrine, nutritional, metabolic, oncological, hepatological, ophthalmic, respiratory, gastrointestinal, hematological, dermatological, neurological and immune system related diseases and disorders; medicines for use by humans, namely, for use in the treatment of infectious, endocrine, nutritional, metabolic, oncological, hepatological, ophthalmic, respiratory, gastrointestinal, hematological, dermatological, neurological and immune system related diseases and disorders; albuminous preparations for medical purposes, namely, for use in the treatment of infectious, endocrine, nutritional, metabolic, oncological, hepatological, ophthalmic, respiratory, gastrointestinal, hematological, dermatological, neurological and immune system related diseases and disorders; stem cells for medical purposes; surgical dressings; diagnostic preparations for medical purposes; chemical preparations for medical purposes, namely, for use in the treatment of infectious, endocrine, nutritional, metabolic, oncological, hepatological, ophthalmic, respiratory, gastrointestinal, hematological, dermatological, neurological and immune system related diseases and disorders; biological tissue cultures for medical purposes | SECTION 71 - CANCELLED | — |
| 010 | Medical apparatus and instruments for treating cardiovascular, infectious, endocrine, nutritional, metabolic, oncological, hepatological, ophthalmic, respiratory, gastrointestinal, hematological, dermatological, neurological and immune system related diseases; testing apparatus for medical purposes in the field of cancer, hepatology, ophthalmology, gastroenterology, hematology, dermatology, neurology, immunology, and infectious diseases; suture materials; surgical thread; surgical implants comprised of artificial materials; surgical cell implants comprised of natural, non-living materials; surgical implants consisting primarily of artificial materials and also including biological materials; cell implants made of artificial materials; cell implants comprised of natural, non-living materials; cell implants consisting primarily of artificial materials and also including biological materials | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Limited Liability Company "NEARMEDIC PLUS"
- Other trademarks owned by Limited Liability Company "NEARMEDIC PLUS"
- Other trademarks owned by Limited Liability Company "NEARMEDIC PLUS"
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 010
- Similar marks named NEARMEDIC
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 29, 2025 | DENA | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED | — |
| Aug 29, 2025 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Apr 23, 2023 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| Mar 22, 2023 | XXSS | GENERIC MADRID TRANSACTION SENT TO IB | — |
| Mar 22, 2023 | XXCR | GENERIC MADRID TRANSACTION CREATED | — |
| Feb 3, 2023 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Jun 3, 2022 | C71T | CANCELLED SECTION 71 | — |
| Nov 17, 2020 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| May 5, 2016 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Feb 23, 2016 | XXSS | GENERIC MADRID TRANSACTION SENT TO IB | — |
| Feb 23, 2016 | XXCR | GENERIC MADRID TRANSACTION CREATED | — |
| Feb 17, 2016 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Nov 17, 2015 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Sep 1, 2015 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Sep 1, 2015 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 28, 2015 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Aug 12, 2015 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Aug 12, 2015 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Aug 12, 2015 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jul 28, 2015 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Jul 27, 2015 | ALIE | ASSIGNED TO LIE | — |
| Jul 16, 2015 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 16, 2015 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jul 15, 2015 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 1, 2015 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 1, 2015 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 1, 2015 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Apr 30, 2015 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Apr 30, 2015 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Apr 30, 2015 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Apr 10, 2015 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Apr 10, 2015 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 10, 2015 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 10, 2015 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 20, 2015 | RFNT | REFUSAL PROCESSED BY IB | — |
| Feb 4, 2015 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Feb 4, 2015 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Feb 3, 2015 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Feb 3, 2015 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Feb 2, 2015 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 30, 2015 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 30, 2015 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jan 29, 2015 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |